Controlled release formulation of erythromycin derivatives
Details for Australian Patent Application No. 2004238253 (hide)
International Classifications
Event Publications
24 November 2005 PCT application entered the National Phase
PCT publication WO2004/100880 Priority application(s): WO2004/100880
27 January 2011 Application Accepted
Published as AU-B-2004238253
26 May 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004238257-A method for altering insulin pharmacokinetics
2004238246-Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser